pubmed-article:8109646 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8109646 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:8109646 | lifeskim:mentions | umls-concept:C0740858 | lld:lifeskim |
pubmed-article:8109646 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:8109646 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
pubmed-article:8109646 | lifeskim:mentions | umls-concept:C0009079 | lld:lifeskim |
pubmed-article:8109646 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
pubmed-article:8109646 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:8109646 | pubmed:dateCreated | 1994-3-24 | lld:pubmed |
pubmed-article:8109646 | pubmed:abstractText | The goals of this study were 1) to determine the extent of substance abuse in patients with treatment-resistant schizophrenia and 2) to assess the relevance of such abuse to subsequent response to treatment with clozapine. | lld:pubmed |
pubmed-article:8109646 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8109646 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8109646 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8109646 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8109646 | pubmed:language | eng | lld:pubmed |
pubmed-article:8109646 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8109646 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8109646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8109646 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8109646 | pubmed:month | Mar | lld:pubmed |
pubmed-article:8109646 | pubmed:issn | 0002-953X | lld:pubmed |
pubmed-article:8109646 | pubmed:author | pubmed-author:MeltzerH YHY | lld:pubmed |
pubmed-article:8109646 | pubmed:author | pubmed-author:BuckleyPP | lld:pubmed |
pubmed-article:8109646 | pubmed:author | pubmed-author:ThompsonPP | lld:pubmed |
pubmed-article:8109646 | pubmed:author | pubmed-author:WayLL | lld:pubmed |
pubmed-article:8109646 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8109646 | pubmed:volume | 151 | lld:pubmed |
pubmed-article:8109646 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8109646 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8109646 | pubmed:pagination | 385-9 | lld:pubmed |
pubmed-article:8109646 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:meshHeading | pubmed-meshheading:8109646-... | lld:pubmed |
pubmed-article:8109646 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8109646 | pubmed:articleTitle | Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. | lld:pubmed |
pubmed-article:8109646 | pubmed:affiliation | Department of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland OH 44106. | lld:pubmed |
pubmed-article:8109646 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8109646 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8109646 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109646 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109646 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109646 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8109646 | lld:pubmed |